IMPROVING INSULIN THERAPY WITH NEOSTIGMINE
Abstract
In insulin coma therapy, in those patients who regularly require intravenous injections of glucose to bring them out of coma, the intramuscular injection of 1 or 1½ mg. of neostigmine from 10 to 45 minutes before gavage with 1 quart of 40% sucrose resulted in a 100% elimination of intravenous injections required. This therefore is felt to be an important contribution to insulin coma therapy. In addition it may help materially in the re-establishment of insulin coma therapy at those mental hospitals where it was previously discontinued because of the greater number of personnel required to administer intravenous injections.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
